PARP Cleavage and Caspase Activity to Assess Chemosensitivity
The ultimate aim of cancer therapeutics is to eradicate tumor cells. Upon lethal exposure to chemotherapeutic agents, cells undergo apoptosis-an active, energy-requiring, programmed cell death. Apoptosis follows a well-orchestrated activation of cysteine proteases, known as caspases. In normal conditions, all the caspases exist as inactive procaspases; they require proteolytic cleavage for activation. A variety of methods are currently used to detect procaspases and caspases and their activity. Immunodetection and fluorescent substrates are widely accepted methods that are utilized for this purpose. These methods are described in detail in this chapter.
- Wilms Tumor Gene WT1 as a: Tumor Marker for Leukemic Blast Cells and Its Role in Leukemogenesis
- Pathological Assessment of Ovarian Cancer
- Measuring Gene Expression from Cell Cultures by Quantitative Reverse-Transcriptase Polymerase Chain Reaction
- Isolation of a Purified Epithelial Cell Population from Human Colon
- Apoptosis Assessment by the DNA Diffusion Assay
- Complete Array of HOX Gene Expression by RQ-PCR
- Application of Gene Microarrays in the Study of Prostate Cancer
- High-Throughput and Reliable Protocols for Animal MicroRNA Library Cloning
- Utility of Fine-Needle Aspiration Biopsy for Prospective Analysis of Patients Undergoing Therapy for Metastatic Melanoma
- GFP转染后克隆筛选